Alpine Global Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-101,066
Closed -$10M 464
2019
Q3
$10M Buy
101,066
+49,890
+97% +$4.74M 2.57% 10
2019
Q2
$4.73M Sell
51,176
-18,810
-27% -$1.79M 1.37% 16
2019
Q1
$6.6M Buy
+69,986
New +$6.12M 1.91% 10
2017
Q4
Sell
-5,698
Closed -$831K 312
2017
Q3
$831K Buy
+5,698
New +$776K 0.24% 66
2017
Q2
Sell
-4,952
Closed -$616K 372
2017
Q1
$616K Buy
+4,952
New +$593K 0.16% 110
2015
Q3
Sell
-3,584
Closed -$415K 1222
2015
Q2
$415K Sell
3,584
-777
-18% -$88.8K 0.07% 206
2015
Q1
$503K Sell
4,361
-12,199
-74% -$1.46M 0.16% 137
2014
Q4
$1.85M Buy
+16,560
New +$1.75M 0.33% 73
2014
Q2
Sell
-31,822
Closed -$2.22M 280
2014
Q1
$2.22M Buy
+31,822
New +$2.52M 1.91% 15

Other funds holding CELG

Alpine Global Management's CELG Position: Q4 2019 in Review

Alpine Global Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 101,066 shares — an estimated $10M sold.

Alpine Global Management first reported a position in CELG in Q1 2014 and held it in 9 quarters. The position peaked at $10M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Alpine Global Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Alpine Global Management sold 101,066 Celgene Corp shares in Q4 2019, an estimated $10M.
  • Alpine Global Management first reported a position in Celgene Corp in Q1 2014 and held it in 9 quarters.
  • Alpine Global Management's Celgene Corp position peaked at $10M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Alpine Global Management's 13F filing for Q4 2019, filed 16 Jan 2020.